Mitragynine is the main psychoactive compound of Mitragyna speciosa Korth. (kratom). This alkaloid could render psychotropic effects and is often misused
as a substitute for commercial drugs. Nowadays, the increasing popularity
of kratom has led to the development of a rapid and
effective detection method. The detection of mitragynine in a biological
sample such as urine requires a highly sensitive and specific method
due to the complex nature of mitragynine in urine. Enzyme-linked immunosorbent
assay (ELISA) is well known as a rapid screening method for biological
samples. In this study, a competitive indirect ELISA was successfully
developed using MG-22-OCH3 IgG as a detection antibody
for mitragynine in human urine. The mitragynine immunoassay showed
a limit of detection and a limit of quantification of 0.412 and 1.25
μg/mL, respectively. The measurement range was between 0.01
and 100.0 μg/mL, with a minimal inhibition (IC50) value of 0.152 μg/mL. The developed ELISA was validated
using a gold method such as high-performance liquid chromatography–mass
spectrometry (HPLC-MS). The percentage of recovery and the coefficient
of variation (CV) for the ELISA and LCMS/MS analyses were 84.0–95.70%,
99.20–112.0%, 7.69–9.78%, and 2.86–6.62%, respectively.
This indicates that the developed ELISA is a reliable method that
can be used as a rapid approach for quantifying mitragynine content
in biological samples.